<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font18 { font-size : 18; } .font10 { font-size : 10; } .font27 { font-size : 27; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">and </span>
   <span class="font27">the </span>
   <span class="font18">vaccine </span>
   <span class="font15">for </span>
   <span class="font14">with </span>
   <span class="font14">COVID- </span>
   <span class="font14">are </span>
   <span class="font13">SARS-CoV- </span>
   <span class="font13">vaccines </span>
   <span class="font13">that </span>
   <span class="font13">respiratory </span>
   <span class="font12">immunity </span>
   <span class="font12">viral </span>
   <span class="font12">antibodies </span>
   <span class="font12">from </span>
   <span class="font12">cell </span>
   <span class="font12">against </span>
   <span class="font12">responses </span>
   <span class="font12">vaccination </span>
   <span class="font12">coronavirus </span>
   <span class="font12">cells </span>
   <span class="font12">clinical </span>
   <span class="font12">immune </span>
   <span class="font12">protein </span>
   <span class="font12">neutralizing </span>
   <span class="font12">human </span>
   <span class="font11">repeated </span>
   <span class="font11">The </span>
   <span class="font11">have </span>
   <span class="font11">virus </span>
   <span class="font11">antibody </span>
   <span class="font11">which </span>
   <span class="font11">protection </span>
   <span class="font11">may </span>
   <span class="font11">not </span>
   <span class="font11">injection </span>
   <span class="font11">response </span>
   <span class="font11">disease </span>
   <span class="font11">doses </span>
   <span class="font11">severe </span>
   <span class="font11">but </span>
   <span class="font11">such </span>
   <span class="font11">infection </span>
   <span class="font11">mucosal </span>
   <span class="font11">two </span>
   <span class="font11">{background </span>
   <span class="font11">trials </span>
   <span class="font11">has </span>
   <span class="font11">safety </span>
   <span class="font11">syndrome </span>
   <span class="font11">will </span>
   <span class="font11">acute </span>
   <span class="font11">been </span>
   <span class="font11">development </span>
   <span class="font11">SARS-CoV </span>
   <span class="font11">can </span>
   <span class="font11">phase </span>
   <span class="font11">most </span>
   <span class="font11">attenuated </span>
   <span class="font11">data </span>
   <span class="font11">mRNA </span>
   <span class="font11">route </span>
   <span class="font11">subunit </span>
   <span class="font11">these </span>
   <span class="font10">Immunol. </span>
   <span class="font10">Phases </span>
   <span class="font10">also </span>
   <span class="font10">protective </span>
   <span class="font10">(Table </span>
   <span class="font10">margin </span>
   <span class="font10">other </span>
   <span class="font10">pre-existing </span>
   <span class="font10">protein; </span>
   <span class="font10">vaccines, </span>
   <span class="font10">NCT </span>
   <span class="font10">induction </span>
   <span class="font10">preclinical </span>
   <span class="font10">trained </span>
   <span class="font10">{border-style </span>
   <span class="font10">inactivated </span>
   <span class="font10">their </span>
   <span class="font10">animal </span>
   <span class="font10">both </span>
   <span class="font10">candidate </span>
   <span class="font10">immunogenicity </span>
   <span class="font10">its </span>
   <span class="font10">px;} </span>
   <span class="font10">studies </span>
   <span class="font10">this </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">Rev. </span>
   <span class="font10">effective </span>
   <span class="font10">require </span>
   <span class="font10">Infect. </span>
   <span class="font10">antigens </span>
   <span class="font10">delivery </span>
   <span class="font10">high </span>
   <span class="font10">host </span>
   <span class="font10">memory </span>
   <span class="font10">proteins </span>
   <span class="font10">recombinant </span>
   <span class="font10">single </span>
   <span class="font10">strategies </span>
   <span class="font10">However, </span>
   <span class="font10">antivector </span>
   <span class="font10">candidates </span>
   <span class="font10">innate </span>
   <span class="font10">only </span>
   <span class="font10">particularly </span>
   <span class="font10">patients </span>
   <span class="font10">platforms </span>
   <span class="font10">than </span>
   <span class="font10">Expressing </span>
   <span class="font10">This </span>
   <span class="font10">based </span>
   <span class="font10">coronaviruses </span>
   <span class="font10">cross-reactive </span>
   <span class="font10">induced </span>
   <span class="font10">mice </span>
   <span class="font10">parenteral </span>
   <span class="font10">potential </span>
   <span class="font10">released </span>
   <span class="font10">there </span>
   <span class="font10">Med. </span>
   <span class="font10">SARS </span>
   <span class="font10">after </span>
   <span class="font10">being </span>
   <span class="font10">induce </span>
   <span class="font10">influenza </span>
   <span class="font10">known </span>
   <span class="font10">levels </span>
   <span class="font10">lung </span>
   <span class="font10">models </span>
   <span class="font10">more </span>
   <span class="font10">showing </span>
   <span class="font10">whether </span>
   <span class="font10">Although </span>
   <span class="font10">Dis. </span>
   <span class="font10">Parenteral </span>
   <span class="font10">These </span>
   <span class="font10">adjuvant </span>
   <span class="font10">developed </span>
   <span class="font10">early </span>
   <span class="font10">following </span>
   <span class="font10">indicate </span>
   <span class="font10">individuals </span>
   <span class="font10">infection. </span>
   <span class="font10">macrophages </span>
   <span class="font10">those </span>
   <span class="font10">through </span>
   <span class="font10">viral-vectored </span>
   <span class="font10">virus, </span>
   <span class="font10">(). </span>
   <span class="font10">ADE </span>
   <span class="font10">DNA </span>
   <span class="font10">Inactivated </span>
   <span class="font10">Published </span>
   <span class="font10">Virol. </span>
   <span class="font10">design </span>
   <span class="font10">dose </span>
   <span class="font10">efficacy </span>
   <span class="font10">healthy </span>
   <span class="font10">highly </span>
   <span class="font10">inflammatory </span>
   <span class="font10">pandemic </span>
   <span class="font10">remains </span>
   <span class="font10">requires </span>
   <span class="font10">safe </span>
   <span class="font10">some </span>
   <span class="font10">they </span>
   <span class="font10">titres </span>
   <span class="font10">ACE </span>
   <span class="font10">China </span>
   <span class="font10">Information </span>
   <span class="font10">SARS-CoV-, </span>
   <span class="font10">associated </span>
   <span class="font10">current </span>
   <span class="font10">global </span>
   <span class="font10">heterologous </span>
   <span class="font10">immunity. </span>
   <span class="font10">into </span>
   <span class="font10">live </span>
   <span class="font10">mouse </span>
   <span class="font10">platform </span>
   <span class="font10">reported </span>
   <span class="font10">required </span>
   <span class="font10">robust </span>
   <span class="font10">role </span>
   <span class="font10">several </span>
   <span class="font10">spike </span>
   <span class="font10">strategy </span>
   <span class="font10">unclear </span>
   <span class="font10">use </span>
   <span class="font10">vaccine-induced </span>
   <span class="font10">vectors </span>
   <span class="font10">who </span>
   <span class="font10">(COVID-) </span>
   <span class="font10">(IM) </span>
   <span class="font10">Furthermore, </span>
   <span class="font10">Multiple </span>
   <span class="font10">NCT, </span>
   <span class="font10">Protein </span>
   <span class="font10">RNA </span>
   <span class="font10">USA </span>
   <span class="font10">Vaccine </span>
   <span class="font10">ability </span>
   <span class="font10">adenovirus </span>
   <span class="font10">al. </span>
   <span class="font10">al.Safety </span>
   <span class="font10">asymptomatic </span>
   <span class="font10">cellular </span>
   <span class="font10">develop </span>
   <span class="font10">different </span>
   <span class="font10">humans </span>
   <span class="font10">immunological </span>
   <span class="font10">including </span>
   <span class="font10">induces </span>
   <span class="font10">infections </span>
   <span class="font10">likely </span>
   <span class="font10">owing </span>
   <span class="font10">protein, </span>
   <span class="font10">receptor </span>
   <span class="font10">serotype </span>
   <span class="font10">strong </span>
   <span class="font10">under </span>
   <span class="font10">used </span>
   <span class="font10">vaccination. </span>
   <span class="font10">vaccines. </span>
   <span class="font10">were </span>
   <span class="font10">whereas </span>
   <span class="font10">Clinical </span>
   <span class="font10">Institute </span>
   <span class="font10">Not </span>
   <span class="font10">Thus, </span>
   <span class="font10">activation </span>
   <span class="font10">al.A </span>
   <span class="font10">challenges </span>
   <span class="font10">could </span>
   <span class="font10">further </span>
   <span class="font10">immunization </span>
   <span class="font10">important </span>
   <span class="font10">infected </span>
   <span class="font10">lack </span>
   <span class="font10">nucleic </span>
   <span class="font10">particles </span>
   <span class="font10">provide </span>
   <span class="font10">px; </span>
   <span class="font10">rhesus </span>
   <span class="font10">specific </span>
   <span class="font10">testing </span>
   <span class="font10">trial </span>
   <span class="font10">vaccines: </span>
   <span class="font10">well </span>
   <span class="font10">{font-family </span>
   <span class="font10">COVID-, </span>
   <span class="font10">Ebola </span>
   <span class="font10">IgG </span>
   <span class="font10">Phase </span>
   <span class="font10">RBD </span>
   <span class="font10">Recombinant </span>
   <span class="font10">Strong </span>
   <span class="font10">TRM </span>
   <span class="font10">VLPs </span>
   <span class="font10">Vaccines </span>
   <span class="font10">between </span>
   <span class="font10">case </span>
   <span class="font10">cases </span>
   <span class="font10">cell-mediated </span>
   <span class="font10">cells, </span>
   <span class="font10">challenge </span>
   <span class="font10">common </span>
   <span class="font10">control </span>
   <span class="font10">delivered </span>
   <span class="font10">effects </span>
   <span class="font10">enhancement </span>
   <span class="font10">evidence </span>
   <span class="font10">font-size </span>
   <span class="font10">help </span>
   <span class="font10">hepatitis </span>
   <span class="font10">inducing </span>
   <span class="font10">information </span>
   <span class="font10">mRNA-based </span>
   <span class="font10">natural </span>
   <span class="font10">need </span>
   <span class="font10">new </span>
   <span class="font10">previous </span>
   <span class="font10">rapidly </span>
   <span class="font10">same </span>
   <span class="font10">severity </span>
   <span class="font10">structural </span>
   <span class="font10">study </span>
   <span class="font10">successful </span>
   <span class="font10">target </span>
   <span class="font10">three </span>
   <span class="font10">via </span>
   <span class="font10">was </span>
   <span class="font10">BCG </span>
   <span class="font10">ChAdOx </span>
   <span class="font10">Chinese </span>
   <span class="font10">McMaster </span>
   <span class="font10">None </span>
   <span class="font10">Plasmid </span>
   <span class="font10">Research </span>
   <span class="font10">SARS-CoV-. </span>
   <span class="font10">University, </span>
   <span class="font10">adenovirus; </span>
   <span class="font10">all </span>
   <span class="font10">alum </span>
   <span class="font10">alveolar </span>
   <span class="font10">antigens; </span>
   <span class="font10">bind </span>
   <span class="font10">currently </span>
   <span class="font10">double; </span>
   <span class="font10">evaluation </span>
   <span class="font10">expressing </span>
   <span class="font10">generally </span>
   <span class="font10">generated </span>
   <span class="font10">had </span>
   <span class="font10">immunity, </span>
   <span class="font10">immunogenic </span>
   <span class="font10">launched </span>
   <span class="font10">lethal </span>
   <span class="font10">low </span>
   <span class="font10">measles </span>
   <span class="font10">mediate </span>
   <span class="font10">might </span>
   <span class="font10">modified </span>
   <span class="font10">monocytes </span>
   <span class="font10">multiple </span>
   <span class="font10">non-replicating </span>
   <span class="font10">often </span>
   <span class="font10">outbreak </span>
   <span class="font10">over </span>
   <span class="font10">pathogens </span>
   <span class="font10">populations </span>
   <span class="font10">prime–boost </span>
   <span class="font10">protects </span>
   <span class="font10">responses, </span>
   <span class="font10">results </span>
   <span class="font10">trialLancet </span>
   <span class="font10">tuberculosis </span>
   <span class="font10">type </span>
   <span class="font10">type- </span>
   <span class="font10">vitro </span>
   <span class="font10">waning </span>
   <span class="font10">when </span>
   <span class="font10">within </span>
   <span class="font10">years </span>
   <span class="font10">(Box </span>
   <span class="font10">(Fig. </span>
   <span class="font10">(SARS-CoV-) </span>
   <span class="font10">(ref.). </span>
   <span class="font10">Ad, </span>
   <span class="font10">ChAd, </span>
   <span class="font10">Clin. </span>
   <span class="font10">Currently, </span>
   <span class="font10">East </span>
   <span class="font10">Engl. </span>
   <span class="font10">For </span>
   <span class="font10">Health </span>
   <span class="font10">Host </span>
   <span class="font10">IgA </span>
   <span class="font10">I–III </span>
   <span class="font10">Middle </span>
   <span class="font10">Sci. </span>
   <span class="font10">University </span>
   <span class="font10">acid </span>
   <span class="font10">adaptive </span>
   <span class="font10">addition </span>
   <span class="font10">additional </span>
   <span class="font10">adjuvants </span>
   <span class="font10">administration </span>
   <span class="font10">amenable </span>
   <span class="font10">analysis </span>
   <span class="font10">antibody-dependent </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">characterized </span>
   <span class="font10">clearance </span>
   <span class="font10">consideration </span>
   <span class="font10">cytokines </span>
   <span class="font10">depending </span>
   <span class="font10">designed </span>
   <span class="font10">developing </span>
   <span class="font10">development, </span>
   <span class="font10">development. </span>
   <span class="font10">distribution </span>
   <span class="font10">durability </span>
   <span class="font10">during </span>
   <span class="font10">elicits </span>
   <span class="font10">emerging </span>
   <span class="font10">express </span>
   <span class="font10">few </span>
   <span class="font10">humans. </span>
   <span class="font10">inclusion </span>
   <span class="font10">increased </span>
   <span class="font10">infectious </span>
   <span class="font10">intramuscular </span>
   <span class="font10">large </span>
   <span class="font10">lipid </span>
   <span class="font10">macaques </span>
   <span class="font10">macrophage </span>
   <span class="font10">monoclonal </span>
   <span class="font10">nCoV- </span>
   <span class="font10">observed </span>
   <span class="font10">one </span>
   <span class="font10">pathogen </span>
   <span class="font10">people </span>
   <span class="font10">period </span>
   <span class="font10">plasmid </span>
   <span class="font10">pneumonia </span>
   <span class="font10">prevalence </span>
   <span class="font10">production </span>
   <span class="font10">protein-specific </span>
   <span class="font10">published </span>
   <span class="font10">reduced </span>
   <span class="font10">regimen </span>
   <span class="font10">relative </span>
   <span class="font10">relevant </span>
   <span class="font10">resulting </span>
   <span class="font10">risk </span>
   <span class="font10">safety, </span>
   <span class="font10">seem </span>
   <span class="font10">should </span>
   <span class="font10">solid; </span>
   <span class="font10">surface </span>
   <span class="font10">unexposed </span>
   <span class="font10">vaccinated </span>
   <span class="font10">vaccine, </span>
   <span class="font10">various </span>
   <span class="font10">viruses </span>
   <span class="font10">what </span>
   <span class="font10">widely </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">&amp;amp; </span>
   <span class="font10">Adjuvant </span>
   <span class="font10">Australia </span>
   <span class="font10">Box </span>
   <span class="font10">Canada </span>
   <span class="font10">ChiCTR </span>
   <span class="font10">ChiCTR, </span>
   <span class="font10">DNA-based </span>
   <span class="font10">III </span>
   <span class="font10">Immunother. </span>
   <span class="font10">Induced </span>
   <span class="font10">Interim </span>
   <span class="font10">Lipid </span>
   <span class="font10">Ltd </span>
   <span class="font10">MERS </span>
   <span class="font10">Medical </span>
   <span class="font10">Microbiol. </span>
   <span class="font10">Operation </span>
   <span class="font10">Therefore, </span>
   <span class="font10">Unimpeded </span>
   <span class="font10">VSV </span>
   <span class="font10">Vaccin. </span>
   <span class="font10">Virus-like </span>
   <span class="font10">Warp </span>
   <span class="font10">Weak </span>
   <span class="font10">about </span>
   <span class="font10">acid-based </span>
   <span class="font10">adults </span>
   <span class="font10">advanced </span>
   <span class="font10">aged </span>
   <span class="font10">although </span>
   <span class="font10">and/or </span>
   <span class="font10">antiviral </span>
   <span class="font10">any </span>
   <span class="font10">basis </span>
   <span class="font10">before </span>
   <span class="font10">binding </span>
   <span class="font10">bold </span>
   <span class="font10">boost </span>
   <span class="font10">booster </span>
   <span class="font10">capable </span>
   <span class="font10">cells. </span>
   <span class="font10">clinically </span>
   <span class="font10">consider </span>
   <span class="font10">convalescent </span>
   <span class="font10">countries </span>
   <span class="font10">courier; </span>
   <span class="font10">crucial </span>
   <span class="font10">cytokine </span>
   <span class="font10">defence </span>
   <span class="font10">dengue </span>
   <span class="font10">directly </span>
   <span class="font10">domain </span>
   <span class="font10">double-blind, </span>
   <span class="font10">efficacious </span>
   <span class="font10">em; </span>
   <span class="font10">entered </span>
   <span class="font10">entry </span>
   <span class="font10">epithelial </span>
   <span class="font10">even </span>
   <span class="font10">example, </span>
   <span class="font10">experimental </span>
   <span class="font10">expressed </span>
   <span class="font10">extent </span>
   <span class="font10">factors </span>
   <span class="font10">features </span>
   <span class="font10">first </span>
   <span class="font10">functions </span>
   <span class="font10">generation </span>
   <span class="font10">grid.. </span>
   <span class="font10">homologous </span>
   <span class="font10">how </span>
   <span class="font10">humoral </span>
   <span class="font10">indicates </span>
   <span class="font10">indicating </span>
   <span class="font10">individuals, </span>
   <span class="font10">infection, </span>
   <span class="font10">initially </span>
   <span class="font10">involving </span>
   <span class="font10">landscape </span>
   <span class="font10">major </span>
   <span class="font10">membrane </span>
   <span class="font10">mice. </span>
   <span class="font10">nanoparticle </span>
   <span class="font10">next </span>
   <span class="font10">non-human </span>
   <span class="font10">non-neutralizing </span>
   <span class="font10">numbers </span>
   <span class="font10">offer </span>
   <span class="font10">open-label, </span>
   <span class="font10">polymerase </span>
   <span class="font10">poor </span>
   <span class="font10">potent </span>
   <span class="font10">potentially </span>
   <span class="font10">principles </span>
   <span class="font10">protein. </span>
   <span class="font10">pt;} </span>
   <span class="font10">rapid </span>
   <span class="font10">recently </span>
   <span class="font10">receptor-binding </span>
   <span class="font10">recovered </span>
   <span class="font10">regard, </span>
   <span class="font10">regarding </span>
   <span class="font10">replication </span>
   <span class="font10">report </span>
   <span class="font10">required; </span>
   <span class="font10">selection </span>
   <span class="font10">seniors </span>
   <span class="font10">shown </span>
   <span class="font10">significant </span>
   <span class="font10">species </span>
   <span class="font10">stomatitis </span>
   <span class="font10">strains </span>
   <span class="font10">strategies. </span>
   <span class="font10">suggesting </span>
   <span class="font10">suggests </span>
   <span class="font10">susceptibility </span>
   <span class="font10">susceptible </span>
   <span class="font10">them </span>
   <span class="font10">time </span>
   <span class="font10">tract </span>
   <span class="font10">understand </span>
   <span class="font10">understood </span>
   <span class="font10">until </span>
   <span class="font10">using </span>
   <span class="font10">vaccine: </span>
   <span class="font10">vaccinees </span>
   <span class="font10">vaccinia </span>
   <span class="font10">vector </span>
   <span class="font10">vesicular </span>
   <span class="font10">virulence </span>
   <span class="font10">virus. </span>
   <span class="font10">weakly </span>
   <span class="font10">without </span>
   <span class="font10">world </span>
   <span class="font10">years. </span>
   <span class="font10">yet </span>
   <span class="font10">young </span>
  </p>
 </body>
</html>
